A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report-Reference-Cited by-同舟云学术

A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report

Published:2022 Issue:4 Volume:34 Page:225-232
ISSN:0915-6380
Container-title:The Showa University Journal of Medical Sciences
language:en
Short-container-title:Showa Univ J Med Sci

Author:

Iida Tatsuya¹,Yonemura Hikaru²,Nishiwaki Hiroki³,Miyazaki Tomoaki²,Imai Hideyuki¹,Sugisawa Chiho¹,Koiwa Fumihiko²,Nagasaka Shoichiro¹

Affiliation:

1. Internal Medicine （Diabetes, Metablism and Endocrinology）, Showa University Fujigaoka Hostpital

2. Internal Medicine （Nephrology）, Showa University Fujigaoka Hospital

3. Showa University Research Administration Center （SURAC）

Publisher

The Showa University Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/sujms/34/4/34_225/_pdf

Reference23 articles.

1. 1. Hu X, Chen F. Exogenous insulin antibody syndrome （EIAS）: a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients. Endocr Connect. 2018;7:R47-R55.

2. 2. Yoshida M, Asai M, Miyata M, et al. Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy. Diabetes Res Clin Pract. 2012;96:e55-e56.

3. 3. Hayashi A, Takano K, Kawai S, et al. SGLT2 inhibitors provide an effective therapeutic option for diabetes complicated with insulin antibodies. Endocrine J. 2016;63:187-191.

4. 4. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110-2121.

5. 5. Imagawa A, Hanafusa T, Awata T, et al. Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus. J Diabetes Investig. 2012;3:179-183.